Thursday, 15 October 2026
Hospital spending outpaces primary care, Emergency doctors push GP funding, Mobile GPs reach Queensland aged care
- 01
Hospital spending growth continued to outpace primary care investment
Government and private health spending reached $290.7 billion in 2024–25, equivalent to 10.5% of GDP, according to Australian Institute of Health and Welfare figures. Federal and state governments spent $103.3 billion on hospital services, compared with total primary care spending of $52.6 billion. In real terms, hospital spending rose 4% while primary care investment increased 1.2%, with the latter growth driven by non-government sources. Government expenditure on unreferred medical services, most of which are provided by GPs, was effectively unchanged at $12.24 billion, while federal spending per person fell from $453.80 to $447.20. The figures included the initial tripled bulk-billing incentive but predated its major expansion late last year.
via RACGP newsGP
- 02
Emergency doctors seek stronger GP funding and aged-care incentive redesign
Emergency physicians are calling for increased funding for longitudinal general practice and a redesign of the General Practice in Aged Care Incentive, according to the Australasian College for Emergency Medicine. Older people who saw a regular GP were up to 28% less likely to attend an emergency department or be hospitalised than those who frequently saw new doctors. Between 2018–19 and 2023–24, ED attendances by older people increased by 16%, compared with 4% among younger people. In 2023–24, 53,510 older people spent more than 24 hours in an ED awaiting a bed, while just 54% of those requiring admission left within eight hours. ACEM said current aged-care incentives favoured larger practices and called for equitable increases enabling all general practices to provide residential aged-care services.
via RACGP newsGP
- 03
Mobile GP pilot reaches 24 Queensland aged-care facilities
Better Medical is trialling a mobile GP service for almost 8000 residents across 24 Queensland aged-care facilities, mainly in the state’s southeast. The Your Doctor in Aged Care pilot supports 10 GPs with centralised administration, coordination and clinical services intended to reduce their administrative burden and allow more time for clinical care. Medibank said it developed the program in response to demand for streamlined aged-care GP services, primary care workforce pressures and the need for greater support for GPs caring for older people. A Better Medical spokesperson said the model may expand nationally following the Queensland pilot’s early success, while Amplar Health will help test and refine it.
- 04
Par Health recalls 22 argatroban lots over particulates
Following the earlier methohexital injection recall, Par Health has voluntarily recalled 22 lots of argatroban injection nationwide. The recall covers 250 mg/2.5 mL (100 mg/mL) products and extends to the hospital/user level. Particulate matter in the affected lots was identified as including cellulose and polystyrene. The FDA MedWatch notice provided limited further detail in the supplied text.
via FDA MedWatch
- 05
UK ketone strip recall threatens diabetic ketoacidosis testing capacity
Blood ketone testing for patients at risk of diabetic ketoacidosis may be disrupted across UK hospitals and ambulance services after a product recall. NHS supplier Nova Biomedical withdrew and recalled specified lots of StatStrip ketone test strips because of quality control failures and is continuing to test its stock. New shipments are not expected to reach the UK until the end of the month. The Medicines and Healthcare Products Regulatory Agency warned that reduced testing capacity could delay recognition, assessment, transfer, treatment or monitoring of diabetic ketoacidosis, potentially contributing to critical illness, permanent harm or death.
via BMJ
- 06
Siemens ends general ultrasound sales to focus on cardiac procedures
Siemens Healthineers will stop selling general imaging ultrasound systems and focus on ultrasound used in interventional cardiology and electrophysiology procedures. The company will discontinue sales of its Acuson Sequoia, Redwood, Juniper and Maple brands, while continuing maintenance, software updates and transducer availability for its general ultrasound systems. It will continue selling the Acuson Origin cardiovascular imaging platform, Acuson Freestyle wireless system and P500 portable machine. The shift supports Siemens’ strategy to combine imaging, software and partnerships with heart device companies for image-guided cardiovascular therapy and increasingly complex procedures.
via MedTech Dive
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.